Enabling the Power of Retrospective and Prospective Drug Discovery Research
While registration isn't required, it's highly encouraged.
Join us to learn about the latest tools in target identification and drug discovery using deep proteomic profiling and cell based analysis from experts in the field.
Katherine Donovan, Ph.D. is a Scientist in Eric Fischer's lab at Dana-Farber Cancer Institute. Dr. Donovan's research focus is the development and profiling of small molecules such as “molecular glues” and PROTACs that are able to commandeer E3 Ligase enzymes to induce ubiquitin-mediated targeted protein degradation.
Mark Federici is the Associate Director of Cell Biology at Thermo Fisher Scientific in Carlsbad, California. Mr. Federici drives the advancement of cellbased biological capabilities and development of enabling technologies which provide scientists with a wide variety of research tools, technology platforms and services at every stage of the drug discovery continuum.
Date: Time: March 13, 2019 3:00pm – 4:30pm
Location: The Galleria, 400 Brookline Avenue, Boston, MA Room: Galleria Hall
Join us for a Happy Hour and Networking Event Following the Seminar, 4:30pm – 6:30pm